Latest Roche Laboratories Stories

NUTLEY, N.J., July 1, 2012 /PRNewswire/ -- A jury in New Jersey late Friday returned an $18 million verdict to two former Accutane users against Nutley, N.J.-based pharmaceutical companies Hoffmann La-Roche Inc. and Roche Laboratories, subsidiaries of Roche Holding AG (ROG). The plaintiffs, Katie Rossitto and Riley Wilkinson, took Accutane for treatment of their acne in the 1990s and developed ulcerative colitis--a debilitating, permanent disease--as a result. Each was awarded $9...

Fontus Pharmaceuticals, a specialty pharmaceutical company focused on nephrology and endocrinology, has acquired Rocaltrol from Roche Laboratories. Rocaltrol is a vitamin D analog prescribed by nephrologists for the management of hyperparathyroidism and resultant metabolic bone disease in patients with moderate to severe chronic renal failure and by endocrinologists for the management of hypocalcemia in patients with post-surgical hypoparathyroidism, idiopathic hypoparathyroidism and...